Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. AMV Holdings, d/b/a Kure CBD and Vape
WARNING LETTER
•AMV Holdings, d/b/a Kure CBD and Vape•July 18, 2025

AMV Holdings, d/b/a Kure CBD and Vape – FDA Warning Letter, Jul 18, 2025

Record Details

The FDA issued a Warning Letter to AMV Holdings, operating as Kure CBD and Vape, on July 17, 2025, following an inspection by the Center for Tobacco Products. The inspection revealed that the company sells and distributes e-liquid products in the U.S. without the required premarket authorization, violating the Federal Food, Drug, and Cosmetic Act (FD&C Act). Specifically, the product "Innevape HEISENBERG MENTHOL ORIGINAL BLUE SLUSHIE 6mg 100ml" lacks the necessary marketing authorization and is thus considered adulterated and misbranded under sections 902(6)(A) and 903(a)(6) of the FD&C Act.

The regulatory framework mandates that all new tobacco products, defined as those not marketed in the U.S. before February 15, 2007, must have a premarket authorization order. The FD&C Act, amended by the Consolidated Appropriations Act, 2022, extends FDA jurisdiction to products containing nicotine from any source.

The FDA requires AMV Holdings to take immediate corrective actions, including ceasing the sale and distribution of non-compliant products and submitting a written response within 15 working days. This response should outline the steps taken to address the violations and ensure future compliance. Failure to comply may result in enforcement actions such as civil penalties or product seizure. The company is advised to ensure all products and related marketing comply with the FD&C Act and FDA regulations.

Company
AMV Holdings, d/b/a Kure CBD and Vape
Inspection date
July 18, 2025
Product type
Tobacco
Office
Center for Tobacco Products
Person
  • John E. Verbeten (Director)
View Company Profile

ID · 0a966b54-6d6f-429b-ab29-19d2aab5cf01

Violation Codes10
21 U.S.C. 321(rr)21 U.S.C. 387j(a)21 U.S.C. 387e(j)(1)(A)(ii)21 U.S.C. 387a(b)21 U.S.C. 387j(c)(1)(A)(i)21 U.S.C. 387e(j)(3)21 U.S.C. 387c(a)(6)21 CFR 114121 CFR 1100.121 U.S.C. 387e(j)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AMV Holdings, d/b/a Kure CBD and Vape
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.